CLAPS has its presence in multiple countries. With established presence in South East Asia, Africa, MIDDLE EAST, Latin America, Russia and CIS countries and evolving presence in many regulated and emerging markets. CLAPS is making its presence felt fast in the global pharmaceutical market.
CLAPS operates its International business through various business models like Marketing Model, Tenders, out-licensing, in licensing, Contract manufacturing, Joint Ventures, Distributorship and Strategic alliances in chosen markets.
CLAPS has successfully leveraged its Strategic production, Research & Formulation development competency for supplying affordable quality pharmaceuticals and healthcare services across the globe.
CLAPS enjoys unique position in many private markets because of it’s “know- how” in marketing and highly professional sales and marketing team who are the core power of our competitiveness and guarantee of our success.
CLAPS is in the process of establishing an extensive marketing and distribution network in all the countries. CLAPS pays more attention to expand its product portfolio via registration and launch of novel pharmaceutical products to address the UNMET needs of human beings.
CLAPS has established its Strategic offices in the Russia & CIS countries, Africa, Dubai and Latin America looking into the business potential and the necessity of being at the centre of action.
Russia & CIS markets
Russia, Ukraine, Kazakhstan and Kyrgyzstan
South East Asia
Vietnam, Myanmar, Philippines, Srilanka, Cambodia and Laos
Ethiopia, Kenya, Ghana, Nigeria, Mauritius, Sudan, Uganda, Rwanda, Senegal, Benin and Cameroon
Peru, Colombia, Chile, Caribbean Islands and Venezuela
UAE, Yemen, Iraq and Iran.